[
  {
    "ts": "2025-11-03T13:30:00+00:00",
    "headline": "Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide",
    "summary": "Eli Lilly and Company (NYSE: LLY) announced today plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, located within the Leiden Bio Science Park. This major project will expand Lilly's capacity to produce oral medicines and strengthen the company's global supply chain.",
    "url": "https://finance.yahoo.com/news/lilly-plans-build-3-billion-133000644.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "e5b10a73-ba23-36d8-9613-67d3afe02895",
      "content": {
        "id": "e5b10a73-ba23-36d8-9613-67d3afe02895",
        "contentType": "STORY",
        "title": "Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE: LLY) announced today plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, located within the Leiden Bio Science Park. This major project will expand Lilly's capacity to produce oral medicines and strengthen the company's global supply chain.",
        "pubDate": "2025-11-03T13:30:00Z",
        "displayTime": "2025-11-03T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/e9965c6e3eae765dcd3f40e7006f582c",
          "originalWidth": 400,
          "originalHeight": 200,
          "caption": "SOURCE: Eli Lilly and Company",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/36UMxvUr1pObp.6k8.iqvw--~B/aD0yMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/e9965c6e3eae765dcd3f40e7006f582c.cf.webp",
              "width": 400,
              "height": 200,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qP3YFPzYilHCyDw.YjDX2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/e9965c6e3eae765dcd3f40e7006f582c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lilly-plans-build-3-billion-133000644.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-plans-build-3-billion-133000644.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-03T13:28:00+00:00",
    "headline": "2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon",
    "summary": "The healthcare industry is chock-full of opportunities for long-term investors.",
    "url": "https://www.fool.com/investing/2025/11/03/2-healthcare-stocks-for-individual-investors-with/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "c6c5ab1f-b117-3285-89ef-f1d5ee36aa16",
      "content": {
        "id": "c6c5ab1f-b117-3285-89ef-f1d5ee36aa16",
        "contentType": "STORY",
        "title": "2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon",
        "description": "",
        "summary": "The healthcare industry is chock-full of opportunities for long-term investors.",
        "pubDate": "2025-11-03T13:28:00Z",
        "displayTime": "2025-11-03T13:28:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/1205b8606ff2f707949aa52ff195feca",
          "originalWidth": 2121,
          "originalHeight": 1414,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y5wxEnL9Lw1kdclP7rllJQ--~B/aD0xNDE0O3c9MjEyMTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/1205b8606ff2f707949aa52ff195feca.cf.webp",
              "width": 2121,
              "height": 1414,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u3YHMHsoo93p.zrpJLAK7A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/1205b8606ff2f707949aa52ff195feca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/03/2-healthcare-stocks-for-individual-investors-with/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-healthcare-stocks-individual-investors-132800558.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ISRG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-03T09:45:00+00:00",
    "headline": "Prediction: The Next Eli Lilly Might Already Be Trading Under $50",
    "summary": "Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.",
    "url": "https://www.fool.com/investing/2025/11/03/prediction-the-next-eli-lilly-might-already-be-tra/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "8350f6ce-a951-3f34-8b36-bfabdc3741f3",
      "content": {
        "id": "8350f6ce-a951-3f34-8b36-bfabdc3741f3",
        "contentType": "STORY",
        "title": "Prediction: The Next Eli Lilly Might Already Be Trading Under $50",
        "description": "",
        "summary": "Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.",
        "pubDate": "2025-11-03T09:45:00Z",
        "displayTime": "2025-11-03T09:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/2fb45bb40fa377b383d3f06f59f8b275",
          "originalWidth": 1400,
          "originalHeight": 934,
          "caption": "Patient self-administering a shot.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/poKiJEjtTvpX5jGSqGjL8Q--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/2fb45bb40fa377b383d3f06f59f8b275.cf.webp",
              "width": 1400,
              "height": 934,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZEu1Qy_qVT7vYnETBwXGNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/2fb45bb40fa377b383d3f06f59f8b275.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/03/prediction-the-next-eli-lilly-might-already-be-tra/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/prediction-next-eli-lilly-might-094500387.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "VKTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-03T04:06:23+00:00",
    "headline": "Dow Jones Futures Rise; Palantir, Robinhood Earnings Ahead",
    "summary": "The stock market has continued to climb, but it's been tricky. Palantir, Robinhood and AMD lead big earnings this week.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-palantir-robinhood-amd-lead-earnings/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "62d37222-a461-31e5-bd64-dd1c3cd6bdd9",
      "content": {
        "id": "62d37222-a461-31e5-bd64-dd1c3cd6bdd9",
        "contentType": "STORY",
        "title": "Dow Jones Futures Rise; Palantir, Robinhood Earnings Ahead",
        "description": "",
        "summary": "The stock market has continued to climb, but it's been tricky. Palantir, Robinhood and AMD lead big earnings this week.",
        "pubDate": "2025-11-03T04:06:23Z",
        "displayTime": "2025-11-03T04:06:23Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/62d37222-a461-31e5-bd64-dd1c3cd6bdd9/dow-jones-futures-rise-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/912bce6dcb055a351bef5b1212da1763",
          "originalWidth": 1000,
          "originalHeight": 565,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XmT4anXp4OywmZOgwDfXbg--~B/aD01NjU7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/912bce6dcb055a351bef5b1212da1763.cf.webp",
              "width": 1000,
              "height": 565,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Wphm8Wz0upbkWRS.vtrO4A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/912bce6dcb055a351bef5b1212da1763.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-palantir-robinhood-amd-lead-earnings/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "IBKR"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "ALAB"
            },
            {
              "symbol": "MDB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-03T03:10:49+00:00",
    "headline": "Cantor Fitzgerald Reaffirms Price Target on Eli Lilly (LLY) Despite GLP-1 Setback",
    "summary": "Eli Lilly & Company (NYSE:LLY) ranks among the stocks with the best earnings growth for the next 5 years. Cantor Fitzgerald reaffirmed its Overweight rating and $925 price target for Eli Lilly & Company (NYSE:LLY) on October 17 following the exclusion of the company’s oral GLP-1 treatment, orforglipron, from the first group of medications to […]",
    "url": "https://finance.yahoo.com/news/cantor-fitzgerald-reaffirms-price-target-031049882.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "d5ee998f-3d1e-37ee-a8e1-15926d66b922",
      "content": {
        "id": "d5ee998f-3d1e-37ee-a8e1-15926d66b922",
        "contentType": "STORY",
        "title": "Cantor Fitzgerald Reaffirms Price Target on Eli Lilly (LLY) Despite GLP-1 Setback",
        "description": "",
        "summary": "Eli Lilly & Company (NYSE:LLY) ranks among the stocks with the best earnings growth for the next 5 years. Cantor Fitzgerald reaffirmed its Overweight rating and $925 price target for Eli Lilly & Company (NYSE:LLY) on October 17 following the exclusion of the company’s oral GLP-1 treatment, orforglipron, from the first group of medications to […]",
        "pubDate": "2025-11-03T03:10:49Z",
        "displayTime": "2025-11-03T03:10:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/324056f0faad680bd4a4c5cc53383c23",
          "originalWidth": 283,
          "originalHeight": 178,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8PhkuSOImzcJWO03ORbAAA--~B/aD0xNzg7dz0yODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/324056f0faad680bd4a4c5cc53383c23.cf.webp",
              "width": 283,
              "height": 178,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LIJLTrtCu6kOCCm8Vfx83Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/324056f0faad680bd4a4c5cc53383c23.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cantor-fitzgerald-reaffirms-price-target-031049882.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cantor-fitzgerald-reaffirms-price-target-031049882.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]